Comparison of efficacy of intralesional vitamin D3 vs intralesional triamcinolone injection in the treatment of keloid
Not Applicable
- Conditions
- Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue
- Registration Number
- CTRI/2022/09/045800
- Lead Sponsor
- SIKSHA O ANUSANDHAN UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
: 1. All patients with keloids above 18 years of age.
2. patients having two or more than two keloids not more than 5cm
3. No treatment done for keloids in last 6 months
Exclusion Criteria
1. Pregnancy and lactation
2. Family history of keloids.
3. Diabetes mellitus.
4.keloids on face
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method esions will be assessed by clinical examination, Vancouver Scar Scale (VSS), digital photograph and Visual Analogue Scale for pain during treatment. <br/ ><br>Timepoint: Assessment will be done at baseline and every 3 weeks and 1 month after last dose. <br/ ><br>
- Secondary Outcome Measures
Name Time Method The clinical improvement will be defined as decreasing values of the scores and complete recovery as scores reach to zero.Timepoint: Scar flattening will be consired as 1mm scar height over 90% of the lesion